Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-036587
Filing Date
2020-11-12
Accepted
2020-11-12 16:45:32
Documents
58
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0920_biomxinc.htm 10-Q 516878
2 FORM OF INDEMNIFICATION AGREEMENT f10q0920ex10-1_biomxinc.htm EX-10.1 100435
3 CERTIFICATION f10q0920ex31-1_biomxinc.htm EX-31.1 14081
4 CERTIFICATION f10q0920ex31-2_biomxinc.htm EX-31.2 14105
5 CERTIFICATION f10q0920ex32_biomxinc.htm EX-32 6916
  Complete submission text file 0001213900-20-036587.txt   3109568

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE phge-20200930.xml EX-101.INS 502675
7 XBRL SCHEMA FILE phge-20200930.xsd EX-101.SCH 41899
8 XBRL CALCULATION FILE phge-20200930_cal.xml EX-101.CAL 35478
9 XBRL DEFINITION FILE phge-20200930_def.xml EX-101.DEF 120003
10 XBRL LABEL FILE phge-20200930_lab.xml EX-101.LAB 261330
11 XBRL PRESENTATION FILE phge-20200930_pre.xml EX-101.PRE 205422
Mailing Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004
Business Address 17 STATE STREET, 16TH FLOOR NEW YORK NY 10004 646-465-9000
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38762 | Film No.: 201307505
SIC: 2836 Biological Products, (No Diagnostic Substances)